Pro Medicus share price rockets 13% on biggest ever contract win

Pro Medicus shares are leaping higher on Thursday.

| More on:
Researchers and doctors with futuristic 3d hologram overlay for body anatomy or dna in hospital clinic.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Pro Medicus Ltd (ASX: PME) share price just took a huge leg up in intraday trading.

Shares in the S&P/ASX 200 Index (ASX: XJO) health imaging company closed yesterday at $228.41. They were trading 1.5% higher at 1.30pm AEDT today before rocketing to $258.87, up 13.3%.

After some likely profit-taking, Pro Medicus shares are currently changing hands for $247.25 each, up 8.4%.

As you can see on the chart below, this sees the Pro Medicus stock up an eye-watering 184% in just 12 months.

Created with Highcharts 11.4.3Pro Medicus PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.com.au

Here's what's spurring ASX 200 investor interest this afternoon.

Pro Medicus share price soars on $330 million deal

The Pro Medicus share price just took off after the company released an intraday update regarding a major new contract.

Pro Medicus reported that its wholly owned United States subsidiary, Visage Imaging, has signed a 10-year $330 million contract with Trinity Health.

Trinity Health is one of the largest not-for-profit healthcare systems in the US, with 93 hospitals, 107 continuing care locations, and 142 urgent care locations.

The contract will see the ASX 200 healthcare stock's cloud-based Visage 7 Enterprise Imaging Platform implemented throughout Trinity to provide a unified diagnostic imaging platform.

Pro Medicus noted that Trinity Health, like all its recent Visage 7 clients, has opted for a fully cloud-based solution. The company said this is a trend that is "fast becoming the standard in the North American healthcare IT market".

Management said that planning for the rollout would start immediately. The rollout will be based on Visage's proven cloud-based implementation process. Multi-phased go-lives are targeted to begin in early Q3 of the 2025 calendar year.

Commenting on the contract sending the Pro Medicus share price soaring, CEO Sam Hupert said:

Trinity Health is our largest customer to date and the first with a national footprint. Our initiative with Trinity Health is noteworthy for its scope and scale which will see the Visage 7 platform used by over 650 Radiologists and thousands of clinicians who will benefit from the proven differentiation of Visage 7…

Our pipeline remains strong and spans all market segments. As has been the case with many of our recent contracts, this deal is for our 'full-stack' comprising all three core Visage products, a trend we see continuing.

If the Pro Medicus share price manages to hold onto the gains at close, as looks likely to me, this will mark another new all-time closing higher for the ASX 200 health imaging company.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A man holds his head in his hands, despairing at the bad result he's reading on his computer.
Healthcare Shares

Cochlear shares sink 9% on guidance downgrade

Investors haven't responded positively to this update. Let's dig deeper into it.

Read more »

Scientists working in the laboratory and examining results.
Healthcare Shares

Telix shares push higher on investor day update

This radiopharmaceuticals company has grand plans for the future.

Read more »

Shot of a young scientist using a digital tablet while working in a lab.
Healthcare Shares

3 leading ASX healthcare shares with global reach

These 3 healthcare companies are having an outsized impact far beyond local markets.

Read more »

Man looks shocked as he works on laptop on top a skyscraper with stockmarket figures in graphic behind him.
Healthcare Shares

Macquarie tips more than 100% upside for this ASX All Ords healthcare stock

This company could be set to soar.

Read more »

A little boy, soon to be a brother, kisses and holds his mum's pregnant tummy.
Healthcare Shares

Monash IVF shares fall 25% following second embryo incident

Its been a forgettable start to 2025 for Monash IVF shareholders.

Read more »

Shot of two young scientists using a laptop in a laboratory.
Healthcare Shares

Buying CSL shares? Meet your new board director

CSL’s new board director has spent the last 11 years in an executive role at Australia’s $240 billion Future Fund.

Read more »

A man sits in contemplation on his sofa looking at his phone as though he has just heard some serious or interesting news.
Technology Shares

Up 60% in two months, is it too late to buy Pro Medicus shares?

Pro Medicus has been delivering solid returns for years. Can the trend continue?

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Healthcare Shares

Why this ASX All Ords stock is jumping 9% today

What has put a rocket under this stock on Friday? Let's find out.

Read more »